Original document(15 pages)  中文版
    The sterile pwoder containing erythromycin salt and M-cholinergic receptor-blocking agent for injection is characterized by that it is a sterile powder for injection which is made up by using erythromycin salt containing 100 portions of erythromycin and M-cholinergic receptor-blocking agent salt containing 0.1-5 portions of M-cholinergic receptor-blocking agent. The described erythromycin salt can optionally select erythromycin lactobionate, and the optimum M-cholinergic receptor-blocking agent is recemic anisodamine hydrochloride. Besides, said sterile powder for injection also can contains proper quantity of diluent and adjuvant, and is made up by adopting spray-drying process, freeze-drying process and direct mixing process. It does not produce side effect of gastrointestinal tract and blood vessel irritation, etc.
Application Number
申请号
02132702 Application Date
申请日
2002.07.31
Title 名称 Injection sterile powder containing erythromycin salt and M cholinergic receptor-blocking agent and its preparation method
Publication Number
公开号
1394608 Publication Date
公开日
2003.02.05
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/14,A61K9/19,A61K31/7048,A61P31/04
Applicant(s) Name
申请人
Shenyang Huatai Medicine Inst.
Address 地址 110016
Inventor(s) Name 发明人
Attorney & Agent 代理人 zhen yuchuo
More information 更  多  信  息


 Related patents information
Surpassing urea
Pressure-difference type continuous liquid density measuring instrument
Circuit of fluorescent lamp electronic ballast
Synchronous birotor combination engine
High-efficency energy-saving coal and gas kettle
Hepatitis A vaccine and its production method
Polyketone polymers
Remote control input method and keyboard of computer
Use of cinnamonum cassia for treating diabetes, its products and preparing method
Veloutine fabric using wool and modified dacron miced spinning and tech. ethereof
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.